ISCHEMATOWN – The company that makes billions of dollars from the sale of a controversial drug contend that it is safe for customers to continue buying it.
The drug from Pferck Laboratories has been the target of a hail of class-action lawsuits, but is “no cause for concern,” said Nathan Therm, an attorney retained by the company to say so.
“There has been some statistical suggestion – suggestion – that Necropsifloxib is less safe than aspirin or placebo,” said Therm. “but there also evidence showing it is less fatal than cyanide tablets in a double-blind clinical trial.”
Necropsifloxib, in various phases under the brand names Rigortin, Mortox and Euthanesta, was marketed as a treatment for osteoarthritis, peptic ulcers, acne vulgaris and hangnail.